BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

BioGaia AB (publ)

IEEE EMBS is an international society focused on biomedical engineering, serving as a central gathering point for engineering, medicine, and biology disciplines.

IEEE EMBS

BioGaia is involved in the research and development of probiotics that support health and well-being across various life stages. Its probiotics are clinically proven.

Metric
Company Name	BioGaia AB (publ)	IEEE EMBS
Symbol	BIOG-B
MSH ID	COM:BIOGAIA	ORG:EMBS
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Drug Manufacturers - Specialty & Generic	Biomedical Engineering
Country	SE	US
Stage
Employee Count	211
Website	biogaia.com	embs.org
LinkedIn
Founders

Metric
Market Cap	1.10B
Enterprise Value
Monthly Web Traffic		266.31K
Web Traffic Growth		0.74
Valuation
Raised Capital

Metric
Revenue	118.62M
Revenue (LTM)
Revenue (NTM)
Gross Profit	86.94M
EBITDA	42.65M
Operating Income	40.34M
Net Income	33.43M
EPS	0.33
Diluted EPS	0.33
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.81
Operating Profit Margin	0.35
EBITDA Margin	0.36
Net Profit Margin	0.29
Return on Equity	0.21
Return on Assets	0.21
Return on Capital Employed	0.28

COM:BIOGAIA

BioGaia

Last Close

105.80

25/11 09:39

Market Cap

11.98B

Beta: -

Volume Today

35.84K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	25.76
P/B Ratio	5.68
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	10.08
EV Multiple	29.31

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding	190.98
Operating Cycle	139.97
Cash Conversion Cycle	88.00
Asset Turnover	0.72

Metric
Operating Cash Flow	38.97M
Free Cash Flow	34.53M
Cash Flow to Debt	12.05
Operating Cash Flow/Sales	0.33
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	141.28M
Accounts Receivable
Inventory
Goodwill	15.11M
Debt to Capitalization	0.02
Debt to Assets
Current Ratio	8.44
Quick Ratio	9.83

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.09
SG&A to Revenue	0.03